Peer-reviewed veterinary case report
Dog with pemphigus vulgaris improved by oclacitinib treatment
By N. Martinez et al.·Published in Veterinary dermatology (Print)·2022·View original on Semantic Scholar →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: A case report of the beneficial effect of oclacitinib in a dog with pemphigus vulgaris.
- Species:
- dog
Plain-English summary
A 5-year-old female dog was diagnosed with pemphigus vulgaris, a serious skin condition caused by the immune system attacking the skin. Traditional treatments often include strong medications, but this dog was successfully treated with oclacitinib, along with a topical cream containing fucidic acid and betamethasone valerate. The combination of these treatments helped improve her skin condition significantly, leading to a positive outcome.
People also search for: dog skin problems pemphigus vulgaris treatment · oclacitinib for dogs · dog immune skin disorder treatment
Abstract
Pemphigus vulgaris is a rare immune-mediated skin disorder of the dog, usually treated with immunosuppressive medications such as oral glucocorticoids, azathioprine or ciclosporin. Herein we report the successful treatment of pemphigus vulgaris in a dog, using oclacitinib and a topical product containing fucidic acid (0.5 % w/w) and betamethasone valerate.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on Semantic Scholar: https://www.semanticscholar.org/paper/35199400